Completed Clinical Trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

By April 24, 2017 No Comments


Malignant Mesothelioma

Estimated Enrollment: 47

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CALGB-30107|U10CA031946|CDR0000269537

Study First Received: February 5, 2003

Last Updated: June 30, 2016

Estimated Primary Completion Date: July 2005


Primary Outcome Measures:

Survival|Failure free survival

Sponsors and Collaborators:

Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now